3.jpg)
Studi Potong Lintang Peresepan Obat Pasien Geriatri di Puskesmas Tangerang: Tinjauan Interaksi Obat
Abstract
Latar Belakang: Pasien geriatri merupakan kelompok pasien yang rentan mengalami efek samping dari interaksi obat mengingat jumlah dan keluhan penyakit yang banyak sehingga pasien geriatri cenderung mendapatkan obat dalam jumlah banyak (polifarmasi) sementara pada saat yang sama fungsi tubuh sudah mulai mengalami penurunan karena proses penuaan. Tujuan: Penelitian ini bertujuan melihat potensi interaksi obat dan faktor-faktor yang mempengaruhi interaksi obat pada pasien geriatri pada sembilan puskesmas di Tangerang. Metode: Penelitian ini dilakukan dengan desain analitik cross-sectional pada data yang diambil selama 14 hari pada sembilan puskesmas di Tangerang dengan metode pengambilan sampel secara purposive total sampling berdasarkan seluruh jumlah pasien geriatri yang diterima. Hasil: Terdapat 270 pasien geriatri (11%) dari total 2410 kunjungan pasien pada sembilan puskesmas di Tangerang selama penelitian. Ditemukan 36 potensi interaksi obat (13%) dari resep obat yang diterima seluruh pasien geriatri. Potensi interaksi obat meningkat bersamaan dengan jumlah pemberian obat (p = 0,00) sementara gender dan usia tidak mempengaruhi potensi interaksi obat pada penelitian ini. Simpulan: Pada penelitian ini didapatkan peningkatan potensi interaksi obat dan terjadi seiring dengan jumlah obat yang diberikan pada pasien geriatri. Dengan demikian, mengurangi jumlah obat pada pasien geriatri dapat mengurangi potensi interaksi obat dan melindungi pasien geriatri terhadap efek samping obat yang tidak diinginkan.
Keywords
Full Text:
PDFReferences
Yang J, Liao Y, Lin W, Wu W. Prescribing errors in electronic prescriptions for outpatients intercepted by pharmacists and the impact of prescribing workload on error rate in a Chinese tertiary-care women and children’s hospital. BMC Health Serv Res. 2019;19(1):1013.
Benet LZ, Bowman CM, Koleske ML, Rinaldi CL, Sodhi JK. Understanding drug-drug interaction and pharmacogenomic changes in pharmacokinetics for metabolized drugs. J Pharmacokinet Pharmacodyn. 2019 Apr;46(2):155–63.
Niu J, Straubinger RM, Mager DE. Pharmacodynamic Drug-Drug Interactions. Clin Pharmacol Ther. 2019 Jun;105(6):1395–406.
Malki MA, Pearson ER. Drug-drug-gene interactions and adverse drug reactions. Pharmacogenomics J. 2020 Jun;20(3):355–66.
Leone R, Magro L, Moretti U, Cutroneo P, Moschini M, Motola D, et al. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy. Drug Saf. 2010 Aug;33(8):667–75.
Schneider KL, Kastenmüller K, Weckbecker K, Bleckwenn M, Böhme M, Stingl JC. Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment. Drugs Aging. 2018 Jun;35(6):559–68.
Muhlack DC, Hoppe LK, Saum K-U, Haefeli WE, Brenner H, Schöttker B. Investigation of a possible association of potentially inappropriate medication for older adults and frailty in a prospective cohort study from Germany. Age Ageing. 2019 Dec;49(1):20–5.
Ministry of Health. Minister of Health Regulations Number 79 Year 2014 Geriatric Patients Services at the Hospital. 2014.
Vrdoljak D, Borovac JA. Medication in the elderly - considerations and therapy prescription guidelines. Acta Med Acad. 2015;44(2):159–68.
Ramsdale E, Mohamed M, Yu V, Otto E, Juba K, Awad H, et al. Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment. Oncologist. 2022 Jul;27(7):e580–8.
Zazzara MB, Palmer K, Vetrano DL, Carfì A, Onder G. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med. 2021 Jun;12(3):463–73.
Sureshkumar K, Srinivasan K, Lingeshwaran GP, Durairaj M, Thiruvengadam G, Mary Martin Daniel PJ, et al. Toxicity profile, adverse drug reactions and drug-drug interactions among geriatric cancer patients under metronomic chemotherapy in a South Indian tertiary care hospital. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract. 2023 Jun;29(4):778–84.
Ahsan Mehdi SM, Meyers B, Nathanson M, Devanand DP. Cervical Dystonia in a Geriatric Patient Associated With Cinacalcet-Clozapine Drug Interaction. J Clin Psychopharmacol. 2022;42(2):214–5.
Nimura S, Kitahara K, Ueshima K, Mochizuki Y, Momo K, Shinke T, et al. Potential drug-drug interaction between tolvaptan and warfarin in a geriatric patient with heart failure. Vol. 10, Clinical case reports. England; 2022. p. e05592.
Welker KL, Mycyk MB. Pharmacology in the Geriatric Patient. Emerg Med Clin North Am. 2016 Aug;34(3):469–81.
Mousavi S, Ghanbari G. Potential drug-drug interactions among hospitalized patients in a developing country. Casp J Intern Med. 2017;8(4):282–8.
Rekić D, Reynolds KS, Zhao P, Zhang L, Yoshida K, Sachar M, et al. Clinical Drug-Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access. J Pharm Sci. 2017 Sep;106(9):2214–8.
Carpenter M, Berry H, Pelletier AL. Clinically Relevant Drug-Drug Interactions in Primary Care. Am Fam Physician. 2019 May;99(9):558–64.
Heringa M, van der Heide A, Floor-Schreudering A, De Smet PAGM, Bouvy ML. Better specification of triggers to reduce the number of drug interaction alerts in primary care. Int J Med Inform. 2018 Jan;109:96–102.
Sari FR, Anwar S, Risahmawati M, Fadhilah M, Ekayanti F. Original A Clinical-Based Drug Interaction Alert (CIDIA) System for Preventing Drug Interaction and Its Associated Factors at Rural Primary Care Centres. Bangladesh J Med Sci. 2023;22(3):667–75.
Gören Z, J Demirkapu M, Akpinar Acet G, Çali S, Gülçebi Idriz Oğlu M. Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care. Turkish J Med Sci. 2017 Feb;47(1):47–54.
Brattig Correia R, de Araújo Kohler LP, Mattos MM, Rocha LM. City-wide electronic health records reveal gender and age biases in administration of known drug-drug interactions. NPJ Digit Med. 2019;2:74.
Merel SE, Paauw DS. Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care. J Am Geriatr Soc. 2017 Jul;65(7):1578–85.
Venturini CD, Engroff P, Ely LS, Zago LF de A, Schroeter G, Gomes I, et al. Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics (Sao Paulo). 2011;66(11):1867–72.
Roblek T, Vaupotic T, Mrhar A, Lainscak M. Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol. 2015 Feb;71(2):131–42.
Dmitriev A V, Filimonov DA, Rudik A V, Pogodin P V, Karasev DA, Lagunin AA, et al. Drug-drug interaction prediction using PASS. SAR QSAR Environ Res. 2019 Sep;30(9):655–64.
Curtain C, Peterson GM. Review of computerized clinical decision support in community pharmacy. J Clin Pharm Ther. 2014 Aug;39(4):343–8.
Ojeleye O, Avery A, Gupta V, Boyd M. The evidence for the effectiveness of safety alerts in electronic patient medication record systems at the point of pharmacy order entry: a systematic review. BMC Med Inform Decis Mak. 2013 Jul;13:69.
Wu H, Xing Y, Ge W, Liu X, Zou J, Zhou C, et al. Drug-drug interaction extraction via hybrid neural networks on biomedical literature. J Biomed Inform. 2020 Jun;106:103432.
Hou WJ, Ceesay B. Extraction of drug-drug interaction using neural embedding. J Bioinform Comput Biol. 2018 Dec;16(6):1840027.
Qian S, Liang S, Yu H. Leveraging genetic interactions for adverse drug-drug interaction prediction. PLoS Comput Biol. 2019 May;15(5):e1007068.
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015 Mar;44(2):213–8.
Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: Evaluating Risks and Deprescribing. Am Fam Physician. 2019 Jul;100(1):32–8.
Munsterhjelm E, Niemi TT, Ylikorkala O, Silvanto M, Rosenberg PH. Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro. Acta Anaesthesiol Scand. 2005 Jul;49(6):840–6.
Kumar V, Venkat Rao N, Siddamsetty RS. Influence of omeprazole on hypoglycaemic activity of glibenclamide and tolbutamide in normal albino rabbits. Acta Pharm Turc. 2000 Apr 4;XLII:135–8.
Fuhrmann S, Koppen A, Seeling A, Knoth H, Schröder J. Analysis of secondary care data to evaluate the clinical relevance of the drug-drug interaction between amlodipine and simvastatin. Z Evid Fortbild Qual Gesundhwes. 2019 Oct;146:21–7.
Sultana N, Arayne MS, Quraishi RU. In vitro interactions of captopril with NSAID’s. Pak J Pharm Sci. 2006 Jul;19(3):202–7.
DOI: https://doi.org/10.24853/mujg.4.2.152-162
Refbacks
- There are currently no refbacks.
Indexed by:
15.jpg)
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial 4.0 Internasional.
Copyright of Muhammadiyah Journal of Geriatric (e issn: 2721-6837)